David Z. D'Argenio - Publications

Affiliations: 
Biomedical Engineering University of Southern California, Los Angeles, CA, United States 
Area:
Biomedical

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chen W, Boras B, Sung T, Hu W, Spilker ME, D'Argenio DZ. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony-Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation. The Aaps Journal. 22: 143. PMID 33156437 DOI: 10.1208/s12248-020-00529-x  0.44
2020 Chen W, D'Argenio DZ, Sipos A, Kim KJ, Crandall ED. Biokinetic Modeling of Nanoparticle Interactions with Lung Alveolar Epithelial Cells: Uptake, Intracellular Processing and Egress. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. PMID 33085912 DOI: 10.1152/ajpregu.00184.2020  0.44
2020 Wang C, Winstein C, D'Argenio DZ, Schweighofer N. The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke. Neurorehabilitation and Neural Repair. 1545968320948609. PMID 32830617 DOI: 10.1177/1545968320948609  0.36
2020 Hu S, D'Argenio DZ. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling. Journal of Pharmacokinetics and Pharmacodynamics. PMID 32500362 DOI: 10.1007/s10928-020-09691-3  0.6
2020 Chen W, Boras B, Sung T, Yu Y, Zheng J, Wang D, Hu W, Spilker ME, D'Argenio DZ. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor. Journal of Pharmacokinetics and Pharmacodynamics. PMID 32162138 DOI: 10.1007/s10928-020-09680-6  0.44
2019 D'Argenio DZ, Bae KS. Analytical solution of linear multi-compartment models with non-zero initial condition and its implementation with R. Translational and Clinical Pharmacology. 27: 43-51. PMID 32055580 DOI: 10.12793/tcp.2019.27.2.43  0.6
2018 Park AYJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. PMID 29914949 DOI: 10.1128/AAC.00550-18  0.56
2017 Bensman TJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses to Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. PMID 28784670 DOI: 10.1128/AAC.00988-17  0.56
2017 Zhang Y, Hu K, Beumer JH, Bakkenist CJ, D'Argenio DZ. RAD-ADAPT: Software for modelling clonogenic assay data in radiation biology. Dna Repair. PMID 28254357 DOI: 10.1016/j.dnarep.2017.02.004  0.72
2016 Dolton MJ, D'Argenio DZ. Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding. The Journal of Antimicrobial Chemotherapy. PMID 28039274 DOI: 10.1093/jac/dkw553  0.52
2016 Zhang Y, D'Argenio DZ. Feedback control indirect response models. Journal of Pharmacokinetics and Pharmacodynamics. PMID 27394724 DOI: 10.1007/s10928-016-9479-8  0.72
2016 Wu LS, Jimmerson LC, Macbrayne CE, Kiser JJ, D'Argenio DZ. Modeling ribavirin-induced anemia in patients with chronic Hepatitis C Virus Cpt: Pharmacometrics and Systems Pharmacology. 5: 65-73. DOI: 10.1002/psp4.12058  0.76
2015 Wu LS, Rower JE, Burton JR, Anderson PL, Hammond KP, Baouchi-Mokrane F, Everson GT, Urban TJ, D'Argenio DZ, Kiser JJ. Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. Antimicrobial Agents and Chemotherapy. 59: 2179-88. PMID 25645847 DOI: 10.1128/AAC.04618-14  0.76
2014 Zhang Y, Hsu CP, Lu JF, Kuchimanchi M, Sun YN, Ma J, Xu G, Zhang Y, Xu Y, Weidner M, Huard J, D'Argenio DZ. FLT3 and CDK4/6 inhibitors: signaling mechanisms and tumor burden in subcutaneous and orthotopic mouse models of acute myeloid leukemia. Journal of Pharmacokinetics and Pharmacodynamics. 41: 675-91. PMID 25326874 DOI: 10.1007/s10928-014-9393-x  0.72
2014 Zhou A, Pacini G, Ahrén B, D'Argenio DZ. Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice. Diabetologia. 57: 801-8. PMID 24370975 DOI: 10.1007/s00125-013-3148-x  0.76
2014 Wang K, D'Argenio DZ, Acosta EP, Sheth AN, Delille C, Lennox JL, Kerstner-Wood C, Ofotokun I. Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients. Clinical Pharmacokinetics. 53: 361-71. PMID 24311282 DOI: 10.1007/s40262-013-0122-1  0.76
2013 Marmarelis VZ, Shin DC, Zhang Y, Kautzky-Willer A, Pacini G, D'Argenio DZ. Analysis of intravenous glucose tolerance test data using parametric and nonparametric modeling: application to a population at risk for diabetes. Journal of Diabetes Science and Technology. 7: 952-62. PMID 23911176 DOI: 10.1177/193229681300700417  0.76
2013 Zhu R, Zheng Y, Putnam WS, Visich J, Eisner MD, Matthews JG, Rosen KE, D'Argenio DZ. Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. The Aaps Journal. 15: 559-70. PMID 23413101 DOI: 10.1208/s12248-013-9463-9  0.76
2013 Pfister M, Mager DE, Holford NHG, Corrigan B, Tannenbaum S, Bruno R, Zhang L, Wang Y, D'Argenio DZ. The International Society of Pharmacometrics Journal of Pharmacokinetics and Pharmacodynamics. 40: S3-S4. DOI: 10.1007/s10928-013-9310-8  0.76
2012 Wu CC, D'Argenio D, Asgharzadeh S, Triche T. TARGETgene: a tool for identification of potential therapeutic targets in cancer. Plos One. 7: e43305. PMID 22952662 DOI: 10.1371/journal.pone.0043305  0.76
2012 Kay BP, Hsu CP, Lu JF, Sun YN, Bai S, Xin Y, D'Argenio DZ. Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab. Journal of Pharmacokinetics and Pharmacodynamics. 39: 577-90. PMID 22932917 DOI: 10.1007/s10928-012-9269-x  0.76
2012 Beumer JH, Parise RA, Kanterewicz B, Petkovich M, D'Argenio DZ, Hershberger PA. A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay. Steroids. 77: 477-83. PMID 22285938 DOI: 10.1016/j.steroids.2012.01.007  0.76
2012 D'Argenio DZ, Gastonguay MR, Brundage RC, Miller R, Tannenbaum SJ, Pfister M. Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics. Journal of Pharmacokinetics and Pharmacodynamics. 39: 3. PMID 22219000 DOI: 10.1007/s10928-011-9237-x  0.76
2012 Beringer PM, Owens H, Nguyen A, Benitez D, Rao A, D'Argenio DZ. Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrobial Agents and Chemotherapy. 56: 70-4. PMID 22024822 DOI: 10.1128/AAC.05710-11  0.76
2012 Zhu R, Kiser JJ, Seifart HI, Werely CJ, Mitchell CD, D'Argenio DZ, Fletcher CV. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid. Journal of Clinical Pharmacology. 52: 511-9. PMID 21558457 DOI: 10.1177/0091270011402826  0.76
2011 Frangi AF, Coatrieux JL, Peng GC, D'Argenio DZ, Marmarelis VZ, Michailova A. Editorial: Special issue on multiscale modeling and analysis in computational biology and medicine--part-1. Ieee Transactions On Bio-Medical Engineering. 58: 2936-42. PMID 21937299 DOI: 10.1109/TBME.2011.2165151  0.76
2011 Beumer JH, Eiseman JL, Gilbert JA, Holleran JL, Yellow-Duke AE, Clausen DM, D'Argenio DZ, Ames MM, Hershberger PA, Parise RA, Bai L, Covey JM, Egorin MJ. Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice. Cancer Chemotherapy and Pharmacology. 67: 421-30. PMID 20443002 DOI: 10.1007/s00280-010-1337-6  0.76
2010 Pfister M, Brundage RC, Gastonguay MR, Miller R, Tannenbaum SJ, D'Argenio DZ. Defining the future of pharmacometrics: the American Society of Pharmacometrics. Journal of Clinical Pharmacology. 50: 158S. PMID 20881230 DOI: 10.1177/0091270010377632  0.76
2010 Brundage RC, Pfister M, D'Argenio DZ, Gastonguay MR, Miller R, Tannenbaum SJ. ACoP: the tools, carpenters, and architects building the discipline of pharmacometrics. Journal of Clinical Pharmacology. 50: 7S-8S. PMID 20881212 DOI: 10.1177/0091270010376967  0.76
2010 Wu CC, Asgharzadeh S, Triche TJ, D'Argenio DZ. Prediction of human functional genetic networks from heterogeneous data using RVM-based ensemble learning. Bioinformatics (Oxford, England). 26: 807-13. PMID 20134029 DOI: 10.1093/bioinformatics/btq044  0.76
2010 Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, Lanni C, Abdelfattah N, Kuppermann B, Csaky KG, D'Argenio DZ, Burke JA, Hughes PM, Robinson MR. Vitreous VEGF clearance is increased after vitrectomy Investigative Ophthalmology and Visual Science. 51: 2135-2138. PMID 20019364 DOI: 10.1167/iovs.09-3582  0.76
2009 Wang X, Schumitzky A, D'Argenio DZ. Population Pharmacokinetic/Pharmacodyanamic Mixture Models via Maximum a Posteriori Estimation. Computational Statistics & Data Analysis. 53: 3907-3915. PMID 20161085 DOI: 10.1016/j.csda.2009.04.017  0.76
2008 Wang J, Weiss M, D'Argenio DZ. A note on population analysis of dissolution-absorption models using the inverse Gaussian function. Journal of Clinical Pharmacology. 48: 719-25. PMID 18359921 DOI: 10.1177/0091270008315956  0.76
2008 Beumer JH, Eiseman JL, Parise RA, Florian JA, Joseph E, D'Argenio DZ, Parker RS, Kay B, Covey JM, Egorin MJ. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice. Cancer Chemotherapy and Pharmacology. 62: 457-64. PMID 18008070 DOI: 10.1007/s00280-007-0625-2  0.76
2007 Wang X, Schumitzky A, D'Argenio DZ. Nonlinear Random Effects Mixture Models: Maximum Likelihood Estimation via the EM Algorithm. Computational Statistics & Data Analysis. 51: 6614-6623. PMID 19756256 DOI: 10.1016/j.csda.2007.03.008  0.76
2006 Beumer JH, Joseph E, Egorin MJ, Parker RS, D'argenio DZ, Covey JM, Eiseman JL. A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5826-33. PMID 17020990 DOI: 10.1158/1078-0432.CCR-06-1234  0.76
2006 Zhou Z, Rodman JH, Flynn PM, Robbins BL, Wilcox CK, D'Argenio DZ. Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents. Antimicrobial Agents and Chemotherapy. 50: 2686-94. PMID 16870759 DOI: 10.1128/AAC.01637-05  0.76
2006 Horton TM, Gannavarapu A, Blaney SM, D'Argenio DZ, Plon SE, Berg SL. Bortezomib interactions with chemotherapy agents in acute leukemia in vitro. Cancer Chemotherapy and Pharmacology. 58: 13-23. PMID 16292537 DOI: 10.1007/s00280-005-0135-z  0.76
2005 Holleran JL, Parise RA, Joseph E, Eiseman JL, Covey JM, Glaze ER, Lyubimov AV, Chen YF, D'Argenio DZ, Egorin MJ. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3862-8. PMID 15897587 DOI: 10.1158/1078-0432.CCR-04-2406  0.76
2003 Xu L, Eiseman JL, Egorin MJ, D'Argenio DZ. Physiologically-based pharmacokinetics and molecular pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite in tumor-bearing mice. Journal of Pharmacokinetics and Pharmacodynamics. 30: 185-219. PMID 14571691 DOI: 10.1023/A:1025542026488  0.76
2003 Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti PS. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats. Cancer Research. 63: 3667-74. PMID 12839957  0.76
2001 Zamboni WC, D'Argenio DZ, Stewart CF, MacVittie T, Delauter BJ, Farese AM, Potter DM, Kubat NM, Tubergen D, Egorin MJ. Pharmacodynamic model of topotecan-induced time course of neutropenia Clinical Cancer Research. 7: 2301-2308. PMID 11489805  0.76
2000 Drusano GL, D'Argenio DZ, Preston SL, Barone C, Symonds W, Lafon S, Rogers M, Prince W, Bye A, Bilello JA. Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir Antimicrobial Agents and Chemotherapy. 44: 1655-1659. PMID 10817724 DOI: 10.1128/AAC.44.6.1655-1659.2000  0.76
2000 Snyder S, D'Argenio DZ, Weislow O, Bilello JA, Drusano GL. The triple combination indinavir-zidovudine-lamivudine is highly synergistic Antimicrobial Agents and Chemotherapy. 44: 1051-1058. PMID 10722511 DOI: 10.1128/AAC.44.4.1051-1058.2000  0.76
2000 Kang D, D'argenio DZ. Bayesian inference in pharmacokinetics/pharmacodynamics using regenerative methods Annals of Biomedical Engineering. 28: S-102.  0.76
1999 Kang D, D'Argenio DZ. Bayesian estimation in pharmacokinetics/pharmacodynamics using regenerative sampling-based methods Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 987.  0.76
1998 Drusano GL, D'Argenio DZ, Symonds W, Bilello PA, McDowell J, Sadler B, Bye A, Bilello JA. Nucleosides analog 1592U89 and human immunodeficiency virus protease inhibitor 141W94 are synergistic in vitro Antimicrobial Agents and Chemotherapy. 42: 2153-2159. PMID 9736527  0.76
1997 D'Argenio DZ, Park K. Uncertain pharmacokinetic/pharmacodynamic systems: Design, estimation and control Control Engineering Practice. 5: 1707-1716. DOI: 10.1016/S0967-0661(97)10025-9  0.76
1996 Siebes M, Campbell CS, D'Argenio DZ. Fluid dynamics of a partially collapsible stenosis in a flow model of the coronary circulation Journal of Biomechanical Engineering. 118: 489-497. PMID 8950652  0.76
1996 D'Argenio DZ, Rodman JH, Robbins BL, Fridland A. Modeling the cellular kinetics of the antiviral agents PMEA and PMPA Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 5: 1903-1904.  0.76
1995 Williams LE, Odom-Maryon TL, Liu A, Chai A, Raubitschek AA, Wong JY, D'Argenio DZ. On the correction for radioactive decay in pharmacokinetic modeling. Medical Physics. 22: 1619-26. PMID 8551986 DOI: 10.1118/1.597421  0.76
1993 Kayne LH, D'Argenio DZ, Meyer JH, Ming Shu Hu, Jamgotchian N, Lee DBN. Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach Journal of Clinical Investigation. 91: 915-922. PMID 8450069  0.76
1993 D'Argenio DZ, Rodman JH. Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective Journal of Pharmacokinetics and Biopharmaceutics. 21: 223-251. PMID 8229682 DOI: 10.1007/BF01059772  0.76
1993 Park K, D'Argenio DZ. Stochastic control of pharmacodynamic processes Proceedings of the Annual Conference On Engineering in Medicine and Biology. 15: 973-974.  0.76
1990 Maneval DC, D'Argenio DZ, Wolf W. A kinetic model for99mTc-DMSA in the rat European Journal of Nuclear Medicine. 16: 29-34. PMID 2155115 DOI: 10.1007/BF01566009  0.76
1990 D'Argenio DZ. Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments Mathematical Biosciences. 99: 105-118. PMID 2134510 DOI: 10.1016/0025-5564(90)90141-K  0.76
1990 Siebes M, D'Argenio DZ. Mathematical model of flow through a partially collapsible coronary stenosis American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 17: 139-142.  0.76
1990 D'Argenio DZ. Control of sparse data systems: Anticancer drug therapy Proceedings of the Annual Conference On Engineering in Medicine and Biology. 1019-1020.  0.76
1989 D'Argenio DZ, Maneval DC. Estimation approaches for modeling sparse data systems Ifac Proceedings Series. 61-67.  0.76
1989 Katz D, D'Argenio DZ. Stochastic control of pharmaco-kinetic systems. Open-loop feedback strategies Ifac Proceedings Series. 391-396.  0.76
1989 Shadmehr R, D'Argenio DZ. Connectionist modeling vs. Bayesian procedures for sparse data pharmacokinetic parameter estimation Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 11: 2058-2059.  0.76
1989 Siebes M, D'Argenio DZ. In vitro study on the pressure drop-flow relationship of a compliant coronary stenosis Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 11: 101-102.  0.76
1988 D'Argenio DZ, Schumitzky A, Wolf W. Simulation of linear compartment models with application to nuclear medicine kinetic modeling Computer Methods and Programs in Biomedicine. 27: 47-54. PMID 3409681 DOI: 10.1016/0169-2607(88)90102-2  0.76
1988 Kurland IJ, D'Argenio DZ. A minimal model of liver glycogen metabolism; feasibility for predicting flux rates Journal of Theoretical Biology. 135: 343-358. PMID 3256724 DOI: 10.1016/S0022-5193(88)80249-2  0.76
1987 Zimmerman RC, SooHoo JB, Kremer JN, D'Argenio DZ. Evaluation of variance approximation techniques for non-linear photosynthesis-irradiance models Marine Biology. 95: 209-215. DOI: 10.1007/BF00409007  0.76
1986 Katz D, D'Argenio DZ. Implementation and evaluation of control strategies for individualizing dosage regimens, with application to the aminoglycoside antibiotics Journal of Pharmacokinetics and Biopharmaceutics. 14: 523-537. PMID 3806374 DOI: 10.1007/BF01059659  0.76
1986 Brechner RR, D'Argenio DZ, Dahalan R, Wolf W. Noninvasive estimation of bound and mobile platinum compounds in the kidney using a radiopharmacokinetic model Journal of Pharmaceutical Sciences. 75: 873-877. PMID 3783454  0.76
1985 Siebes M, D'Argenio DZ, Selzer RH. Computer assessment of hemodynamic severity of coronary artery stenosis from angiograms Computer Methods and Programs in Biomedicine. 21: 143-152. PMID 3853488 DOI: 10.1016/0169-2607(85)90075-6  0.76
1984 Katz D, D'Argenio DZ. Discrete approximation of multivariate densities with application to Bayesian estimation Computational Statistics and Data Analysis. 2: 27-36. DOI: 10.1016/0167-9473(84)90030-6  0.76
1984 D'Argenio DZ, Katz D, Schumitzky A, Jelliffe RW. STOCHASTIC CONTROL OF DRUG THERAPY: OPEN-LOOP FEEDBACK Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 246.  0.76
1983 D'Argenio DZ, Khakmahd K. Adaptive control of theophylline therapy: Importance of blood sampling times Journal of Pharmacokinetics and Biopharmaceutics. 11: 547-559. PMID 6668559 DOI: 10.1007/BF01062211  0.76
1983 D'Argenio DZ, Katz D. Sampling strategies for noncompartmental estimation of mean residence time Journal of Pharmacokinetics and Biopharmaceutics. 11: 435-446. PMID 6668552 DOI: 10.1007/BF01058960  0.76
1983 Katz D, D'Argenio DZ. Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies Biometrics. 39: 621-628. PMID 6652198  0.76
1983 Jelliffe RW, Schumitzky A, D'Argenio DZ, Katz D, Rodman J. IMPROVED 2-COMPARTMENT TIME-SHARED PROGRAMS FOR ADAPTIVE CONTROL OF DIGITOXIN AND DIGOXIN THERAPY Proceedings - Annual Symposium On Computer Applications in Medical Care. 231-234.  0.76
1982 Lewis SM, D'Argenio DZ, Bekey GA, Mittman C. Optimal inputs for parameter determination of inert gas washout from the lung. Respiration Physiology. 50: 111-27. PMID 6294774 DOI: 10.1016/0034-5687(82)90011-1  0.76
1982 D'Argenio DZ, Khakmahd K. Importance of sampling times when estimating theophylline (T) clearance Drug Intelligence and Clinical Pharmacy. 16: No. 13.  0.76
1981 D'Argenio DZ. Optimal sampling times for pharmacokinetic experiments Journal of Pharmacokinetics and Biopharmaceutics. 9: 739-756. PMID 7341758 DOI: 10.1007/BF01070904  0.76
1979 D'argenio DZ, Schumitzky A. A program package for simulation and parameter estimation in pharmacokinetic systems Computer Programs in Biomedicine. 9: 115-134. PMID 761456 DOI: 10.1016/0010-468X(79)90025-4  0.76
Show low-probability matches.